# University of British Columbia: Early phase 1 study started recruiting, 20 planned (Healthy Adult)

**Score:** 35/100

| Field | Value |
|---|---|
| Sponsor | University of British Columbia |
| Sponsor type | Academic and hospital |
| Study | Ivabradine for Heart Rate Reduction During Exercise in Healthy Adults |
| NCT ID | NCT07717710 |
| Phase | Early phase 1 |
| Status | recruiting |
| Conditions | Healthy Adult |
| Intervention types | drug |
| Target enrollment | 20 |
| Site countries | Canada |
| Posted | 2026-07-21 |
| Planned start | 2026-10-01 |
| Event | Started recruiting |
| Event date | 2026-10-01 |
| Last update posted | 2026-10-09 |

## Why this score
- Just started recruiting: sites, recruitment and supply are active.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07717710). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.